BioCentury
ARTICLE | Company News

Med Discovery, University of Lausanne deal

June 29, 2009 7:00 AM UTC

Med Discovery received exclusive, worldwide rights to the university's peptides derived from RAS p21 protein activator GTPase activating protein 1 ( RASA1, RASGAP, p120GAP), which have been shown t...